SELENA CARMONA: Open Payments
NPI 1558957076 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$245 in 9 payments from 7 companies in 2025. Trend: 2023 $227 · 2024 $497 · 2025 $245
Food & beverage: $245
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $64 |
| Celgene Corporation | 2 | $51 |
| TAIHO ONCOLOGY, INC. | 1 | $35 |
| SOBI, INC | 1 | $34 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Incyte Corporation | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
Products named: SCEMBLIX, INQOVI, Vonjo, REBLOZYL, OJJAARA, JAKAFI, BREYANZI, DANZITEN.
Industry payments across TX — which companies pay providers there.
